Literature DB >> 15911610

ATP-independent activation of natriuretic peptide receptors.

Laura K Antos1, Sarah E Abbey-Hosch, Darcy R Flora, Lincoln R Potter.   

Abstract

Natriuretic peptide receptor A (NPR-A) is an essential cardiovascular regulator that is stimulated by atrial natriuretic peptide and B-type natriuretic peptide, whereas natriuretic peptide receptor B (NPR-B) stimulates long bone growth in a C-type natriuretic peptide-dependent manner. Many reports indicate that ATP is essential for NPR-A and NPR-B activation. Current models suggest that natriuretic peptide binding to receptor extracellular domains causes ATP binding to intracellular kinase homology domains, which derepresses adjacent catalytic domains. Here, we report 100-fold activations of natriuretic peptide receptors in the absence of ATP. The addition of a nonhydrolyzable ATP analog had no effect at early time periods (measured in seconds) but increased cGMP production about 2-fold after longer incubations (measured in minutes), consistent with a stabilization, not activation, mechanism. These data indicate that ATP does not activate natriuretic peptide receptors as has been repeatedly reported. Instead, ATP increases activity primarily by maintaining proper receptor phosphorylation status but also serves a previously unappreciated enzyme stabilizing function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15911610     DOI: 10.1074/jbc.M505648200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

Review 1.  Regulation and therapeutic targeting of peptide-activated receptor guanylyl cyclases.

Authors:  Lincoln R Potter
Journal:  Pharmacol Ther       Date:  2010-12-24       Impact factor: 12.310

Review 2.  Membrane guanylyl cyclase receptors: an update.

Authors:  David L Garbers; Ted D Chrisman; Phi Wiegn; Takeshi Katafuchi; Joseph P Albanesi; Vincent Bielinski; Barbara Barylko; Margaret M Redfield; John C Burnett
Journal:  Trends Endocrinol Metab       Date:  2006-06-30       Impact factor: 12.015

3.  Mass spectrometric identification of phosphorylation sites in guanylyl cyclase A and B.

Authors:  Andrea R Yoder; Matthew D Stone; Timothy J Griffin; Lincoln R Potter
Journal:  Biochemistry       Date:  2010-11-08       Impact factor: 3.162

4.  Atrial natriuretic factor receptor guanylate cyclase signaling: new ATP-regulated transduction motif.

Authors:  Teresa Duda; Shashank Bharill; Ireneusz Wojtas; Prem Yadav; Ignacy Gryczynski; Zygmunt Gryczynski; Rameshwar K Sharma
Journal:  Mol Cell Biochem       Date:  2009-01-10       Impact factor: 3.396

5.  The linker region in receptor guanylyl cyclases is a key regulatory module: mutational analysis of guanylyl cyclase C.

Authors:  Sayanti Saha; Kabir Hassan Biswas; Chandana Kondapalli; Nishitha Isloor; Sandhya S Visweswariah
Journal:  J Biol Chem       Date:  2009-07-31       Impact factor: 5.157

Review 6.  Atrial natriuretic factor-receptor guanylate cyclase signal transduction mechanism.

Authors:  Teresa Duda
Journal:  Mol Cell Biochem       Date:  2009-11-26       Impact factor: 3.396

Review 7.  Membrane guanylate cyclase is a beautiful signal transduction machine: overview.

Authors:  Rameshwar K Sharma
Journal:  Mol Cell Biochem       Date:  2009-12-03       Impact factor: 3.396

8.  Allosteric modification, the primary ATP activation mechanism of atrial natriuretic factor receptor guanylate cyclase.

Authors:  Teresa Duda; Prem Yadav; Rameshwar K Sharma
Journal:  Biochemistry       Date:  2011-01-26       Impact factor: 3.162

Review 9.  Structure, signaling mechanism and regulation of the natriuretic peptide receptor guanylate cyclase.

Authors:  Kunio S Misono; John S Philo; Tsutomu Arakawa; Craig M Ogata; Yue Qiu; Haruo Ogawa; Howard S Young
Journal:  FEBS J       Date:  2011-04-07       Impact factor: 5.542

10.  Inhibition of natriuretic peptide receptor 1 reduces itch in mice.

Authors:  Hans Jürgen Solinski; Patricia Dranchak; Erin Oliphant; Xinglong Gu; Thomas W Earnest; John Braisted; James Inglese; Mark A Hoon
Journal:  Sci Transl Med       Date:  2019-07-10       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.